Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2018-10-23 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
第二届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the second meeting of the company's second board of directors. It includes details about the meeting date, attendance, voting results, and references to other documents such as the third quarter report and independent directors' opinions. The document does not contain the full financial report itself but announces decisions made by the board, including approval of the quarterly report and impairment provisions. The length is short (1133 characters), and it primarily serves as a meeting resolution announcement rather than a full financial report or detailed management discussion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2018-10-23 Chinese
关于控股股东部分股票质押式回购交易补充质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the supplementary pledge of shares by its controlling shareholder. It details the number of shares pledged, pledge dates, pledgees, and the proportion of shares pledged relative to total holdings. It explicitly states that this is a supplementary pledge and does not involve new financing arrangements. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledging activity, which fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is Capital/Financing Update (CAP).
2018-10-17 Chinese
关于大股东部分股票质押式回购交易补充质押的公告
Regulatory Filings Classification · 100% confidence The document is a public announcement regarding a shareholder's stock pledge transaction, specifically a supplementary pledge of shares by a major shareholder. It details the number of shares pledged, the pledge dates, and related information. There is no financial report, earnings data, or management discussion. The document is short (1112 characters) and serves as a regulatory disclosure about share pledging activity. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2018-10-15 Chinese
关于控股股东部分股票质押式回购交易补充质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the supplementary pledge of shares by a controlling shareholder. It details the number of shares pledged, pledge dates, pledgees, and the proportion of shares pledged relative to total holdings and company shares. It explicitly states that this is a supplementary pledge and does not involve new financing arrangements. The document is short (1230 characters) and focuses on share pledge information rather than financial results or management discussion. It does not contain financial statements or detailed financial analysis. This type of announcement fits the category of a Regulatory Filing (RNS) as it is a regulatory disclosure about share pledges and does not fit into more specific categories like Capital/Financing Update (CAP) because it states no new financing is involved, nor is it a share issue or capital change (SHA).
2018-10-11 Chinese
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the completion of business registration changes and the issuance of a new business license. It details changes in the company's board and management, amendments to the company charter, and updates to the business scope. The document references prior meeting resolutions and regulatory compliance but does not contain financial statements or detailed financial data. The length is about 3200 characters, which is relatively short and consistent with an announcement rather than a full report. It is not a financial report, earnings release, or management discussion. It is not a proxy statement or voting result announcement. The content is about corporate governance changes and regulatory filings related to business registration and management appointments. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2018-09-26 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the progress of using part of its idle raised funds for cash management through purchasing financial products. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, details specific transactions of financial products purchased with raised funds, discusses risk management measures, and provides a summary of past transactions. The document is relatively short (3233 characters) and focuses on an update about the use of raised funds rather than presenting comprehensive financial statements or results. It does not contain financial statements or detailed financial performance data typical of Annual Reports or Interim Reports. It is not a certification or officer attestation. The content fits best with a Capital/Financing Update (CAP) as it relates to the company's financing activities and use of raised capital for investment purposes.
2018-09-25 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.